• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Benha Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 39 (2022)
Issue Issue 1
Issue Special issue (Ophthalmology)
Volume Volume 38 (2021)
Volume Volume 37 (2020)
Volume Volume 36 (2019)
Al-Badawy, R., Abo-Amer, Y., Zakaria, A., E.Sharaby, R., El.Eraky, T. (2022). Serum Melatonin Levels In Patients with Hepatocellular Carcinoma. Benha Medical Journal, 39(1), 295-308. doi: 10.21608/bmfj.2022.120033.1541
Reda Al-Badawy; Yousry Abo-Amer; Asmaa Zakaria; Radwa E.Sharaby; Tamer E. El.Eraky. "Serum Melatonin Levels In Patients with Hepatocellular Carcinoma". Benha Medical Journal, 39, 1, 2022, 295-308. doi: 10.21608/bmfj.2022.120033.1541
Al-Badawy, R., Abo-Amer, Y., Zakaria, A., E.Sharaby, R., El.Eraky, T. (2022). 'Serum Melatonin Levels In Patients with Hepatocellular Carcinoma', Benha Medical Journal, 39(1), pp. 295-308. doi: 10.21608/bmfj.2022.120033.1541
Al-Badawy, R., Abo-Amer, Y., Zakaria, A., E.Sharaby, R., El.Eraky, T. Serum Melatonin Levels In Patients with Hepatocellular Carcinoma. Benha Medical Journal, 2022; 39(1): 295-308. doi: 10.21608/bmfj.2022.120033.1541

Serum Melatonin Levels In Patients with Hepatocellular Carcinoma

Article 21, Volume 39, Issue 1, March and April 2022, Page 295-308  XML PDF (586.06 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2022.120033.1541
Authors
Reda Al-Badawy1; Yousry Abo-Amer2; Asmaa Zakaria email 3; Radwa E.Sharaby4; Tamer E. El.Eraky5
1Hepatology,Gastroentrology and Infectious Diseases,Benha Faculty of Medicine ,Benha univerisity ,Benha ,Egypt
2Hepatology, Gastroenterology, and Infectious Diseases Department, Mahalla Hepatology Teaching Hospital , Egypt
3Hepatology, Gastroenterology & Infectious diseases, Faculty of Medicine, Banha University
4Clinical Pathology Department, Faculty of Medicine, Tanta University.
5Hepatology, Gastroenterology & Infectious Diseases Department, Faculty of Medicine- Benha University
Abstract
Abstract
Background: HCC accounts for 90% of all primary liver cancers around the world. HCC is the fifth most frequent cancer in the world and the second largest cause of cancer-related death. HCC will be the first indication for liver transplantation by 2030.The need for a marker to detect HCC cases early is critical. Melatonin is a hormone, and when its hemostasis is disrupted by cirrhosis, it may be linked to the development of hepatocellular carcinoma. The aim is to assess blood melatonin levels in patients with liver cirrhosis (compensated and decompensated) and HCC. Subject and Methods: This was a comparative cross-sectional study with 22 patients with compensated liver cirrhosis, 22 patients with decompensated liver cirrhosis, 22 patients with HCC, and 22 healthy subjects as a control group. Laboratory tests, as well as abdominal ultrasound and spiral CT, were performed as needed. Melatonin levels were measured using an ELISA kit in accordance with the manufacturer's instructions. Results: In compensated liver cirrhosis, there was a statistically significant positive correlation between serum melatonin and age, as well as a significant positive correlation between melatonin, (Hb), (WBCs), and (platelets) in decompensated liver cirrhosis. Serum melatonin has low statistical sensitivity, specificity, and predictive value. Conclusion: The melatonin levels in the compensated, decompensated and HCC groups were lower than in the control groups, the difference was not statistically significant. Abbreviations: HCC / Hepatocellular carcinoma. CT/ Computed tomography. ELISA /Enzyme-linked immunoassay. Hb / Hemoglobin. WBCs/ White blood cells
Keywords: Liver Cirrhosis, Hepatocellular Carcinoma (HCC), Apoptosis, Melatonin.
Keywords
Liver Cirrhosis; Hepatocellular Carcinoma (HCC); Apoptosis; Melatonin
Statistics
Article View: 52
PDF Download: 35
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.